Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

380 results
Display

Upregulated Long Noncoding RNA LINC01234 Predicts Unfavorable Prognosis for Colorectal Cancer and Negatively Correlates With KLF6 Expression

Jiang X, Zhu Q, Wu P, Zhou F, Chen J

BACKGROUND: LINC01234, a long noncoding RNA (lncRNA), is overexpressed in several cancers, including colorectal cancer (CRC). We investigated the role of LINC01234 in CRC development and confirmed its correlation with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Usefulness of Chromosomal Microarray in Hematologic Malignancies: A Case of Aggressive NK-cell Leukemia with 1q Abnormality

Chung YN, Kim HN, Lee SR, Sung HJ, Nam MH

A variety of clonal cytogenetic abnormalities have been reported in aggressive natural killer (NK)-cell lymphoma and leukemia. Recent chromosomal microarray studies have shown both gain and loss of 1q and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical significance of variants of unknown significances in BRCA genes

Choi MC

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Roles of miRNAs in Medulloblastoma: A Systematic Review

Mollashahi B, Aghamaleki FS, Movafagh A

Medulloblastoma is considered one of the most threatening malignant brain tumors with an extremely high mortality rate in children. In the medulloblastoma, there are several genes and mutations found to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells

You MH, Jeon MJ, Kim TY, Kim WB, Shong YK, Kim WG

BACKGROUND: We previously reported the frequent neurofibromatosis 2 (NF2) gene mutations in anaplastic thyroid cancers in association with the BRAF V600E mutation. We aimed to investigate the role of NF2 in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway

Liang Y, Wang S, Liu J

PURPOSE: Tumor protein p53-regulated apoptosis-inducing protein 1 (TP53AIP1) functions in various cancers. We studied the effect and molecular mechanism of TP53AIP1 in breast cancer. METHODS: The degree of correlation between TP53AIP1...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of PTEN Polymorphism on the Development of Hepatitis B Virus-associated Hepatocellular Carcinoma

Kim SS, Eun JW, Cho HJ, Lee HY, Seo CW, Lee GH, Yoon SY, Noh CK, Cho SW, Cheong JY

BACKGROUND/AIMS: Phosphatase and tensin homolog (PTEN) is a known tumor suppressor gene that is downregulated in hepatocellular carcinoma (HCC). Here, we investigated the association between single nucleotide polymorphisms (SNPs) of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Genistein Inhibits Proliferation of BRCA1 Mutated Breast Cancer Cells: The GPR30-Akt Axis as a Potential Target

Kim GY, Suh J, Jang JH, Kim DH, Park OJ, Park SK, Surh YJ

BACKGROUND: BRCA1 mutated breast cancer cells exhibit the elevated cell proliferation and the higher metastatic potential. G protein-coupled receptor 30 (GPR30) has been shown to regulate growth of hormonally responsive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers

Won HS, Chang ED, Na SJ, Whang IY, Lee DS, You SH, Kim YS, Kim JS

PTEN hamartoma tumor syndrome is a spectrum of disorders characterized by unique phenotypic features including multiple hamartomas caused by mutations of the tumor suppressor gene PTEN. Cowden syndrome and Bannayan–Riley–Ruvalcaba...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Deficiency of Follistatin-Like Protein 1 Accelerates the Growth of Breast Cancer Cells at Lung Metastatic Sites

Zhang Y, Xu X, Yang Y, Ma J, Wang L, Meng X, Chen B, Qin L, Lu T, Gao Y

PURPOSE: Follistatin-like protein 1 (FSTL1) is a secreted glycoprotein that has been shown to play a role in various types of cancer. However, the clinical significance and function of FSTL1...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serrated neoplasia pathway as an alternative route of colorectal cancer carcinogenesis

Kim SY, Kim TI

In the past two decades, besides conventional adenoma pathway, a subset of colonic lesions, including hyperplastic polyps, sessile serrated adenoma/polyps, and traditional serrated adenomas have been suggested as precancerous lesions...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical and Prognostic Significance of O⁶-Methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Melanoma: A Systematic Meta-Analysis

Qi F, Yin Z, Wang G, Zeng S

Tumor suppressor gene O⁶-methylguanine-DNA methyltransferase (MGMT) promoter methylation has been reported in melanoma. However, the clinical and prognostic significance of MGMT promoter methylation in patients with melanoma remained to be...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Disruption of the Tff1 gene in mice using CRISPR/Cas9 promotes body weight reduction and gastric tumorigenesis

Kim H, Jeong H, Cho Y, Lee J, Nam KT, Lee HW

Trefoil factor 1 (TFF1, also known as pS2) is strongly expressed in the gastrointestinal mucosa and plays a critical role in the differentiation of gastric glands. Since approximately 50% of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Somatic Mutations from Whole Exome Sequencing Analysis of the Patients with Biliary Tract Cancer

Yoon KA, Woo SM, Kim YH, Kong SY, Han SS, Park SJ, Lee WJ

Biliary tract cancer (BTC) is a rare cancer and is associated with a poor prognosis. To understand the genetic characteristics of BTC, we analyzed whole-exome sequencing data and identified somatic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Differences Regarding the Molecular Features and Gut Microbiota Between Right and Left Colon Cancer

Kim K, Castro EJ, Shim H, Advincula , Kim YW

For many years, developmental and physiological differences have been known to exist between anatomic segments of the colorectum. Because of different outcomes, prognoses, and clinical responses to chemotherapy, the distinction...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma

Lee M, Ko H, Yun M

Various molecular targeted therapies and diagnostic modalities have been developed for the treatment of hepatocellular carcinoma (HCC); however, HCC still remains a difficult malignancy to cure. Recently, the focus has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Relation between RASSF1A Methylation and BRAF Mutation in Thyroid Tumor

Oh KH, Jung KY, Baek SK, Woo JS, Cho JG, Kwon SY

BACKGROUND AND OBJECTIVES: Hypermethylation of the tumor suppressor gene RASSF1A and activating mutation of BRAF gene have been recently reported in thyroid cancers. To investigate the role of these two...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epigenetic inactivation of RUNX3 in colorectal cancer

Shin EJ, Kim HJ, Son MW, Ahn TS, Lee HY, Lim DR, Bae SB, Jeon S, Kim H, Jeong D, Lee MS, Kim DS, Noh JS, Baek MJ

PURPOSE: Emerging evidence indicates that runt-related transcription factor 3 (RUNX3) is an important tumor suppressor gene in several cancer types, including colorectal cancer (CRC). However, the clinical significance of RUNX3...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of ionizing radiation at low dose on transgenerational carcinogenesis by epigenetic regulation

Li L, Kim JH, Park HT, Lee JH, Park MK, Lee JW, Lee JC, Lee MJ

The objective of this study was to determine the effect of ionizing radiation (IR) exposure of parents on carcinogenesis of the next generation focusing on the epigenetic perspective to clarify...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy

Yu T, Tang B, Sun X

Hypoxia is frequently observed in solid tumors and also one of the major obstacles for effective cancer therapies. Cancer cells take advantage of their ability to adapt hypoxia to initiate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr